Vince Ippolito

Botanix Pharma – Tell Us Is It Good or Bad?

Yesterday, Botanix Pharma (ASX:BOT), released top-line data from their Phase 2 study evaluating the safety and efficacy of their drug in patients with moderate to severe acne. Bot...

Botanix Pharma – ready for lift-off in 2020

Botanix Pharma - one of our strongest cannabis stock picks - had an issue with its Acne drug Phase 2 results. We speak exclusively to the company and hear - first hand - how they h...